Visual and anatomical outcomes following vitrectomy for complications of diabetic retinopathy: The DRIVE UK Study

NOVEL METHOD FOR ANALYZING SNELLEN VISUAL ACUITY MEASUREMENTS

(2010) Ninel Z Gregori et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

Entry site treatment to prevent late recurrent postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy

(2009) D. H. W. Steel et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Intraoperative bleeding during vitrectomy for diabetic tractional retinal detachment with versus without preoperative intravitreal bevacizumab (IBeTra study)

(2009) D da R Lucena et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Randomized Trial of Intravitreal Bevacizumab Alone or Combined with Triamcinolone versus Macular Photocoagulation in Diabetic Macular Edema

(2009) Masoud Soheilian et al.   OPHTHALMOLOGY

Predictive clinical features and outcomes of vitrectomy for proliferative diabetic retinopathy

(2008) D. Yorston et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Injection of intravitreal bevacizumab (Avastin) as a preoperative adjunct before vitrectomy surgery in the treatment of severe proliferative diabetic retinopathy (PDR)

(2008) Stanislao Rizzo et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

LONG-TERM EFFECT OF INTRAVITREAL BEVACIZUMAB (AVASTIN) IN PATIENTS WITH CHRONIC DIFFUSE DIABETIC MACULAR EDEMA

(2008) DANIEL KOOK et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES